Deep Track Capital, LP Relmada Therapeutics, Inc. Transaction History
Deep Track Capital, LP
- $2.71 Billion
- Q3 2024
A detailed history of Deep Track Capital, LP transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 674,833 shares of RLMD stock, worth $229,443. This represents 0.08% of its overall portfolio holdings.
Number of Shares
674,833
Previous 1,234,773
45.35%
Holding current value
$229,443
Previous $3.7 Million
40.98%
% of portfolio
0.08%
Previous 0.12%
Shares
8 transactions
Others Institutions Holding RLMD
# of Institutions
77Shares Held
11.5MCall Options Held
216KPut Options Held
138K-
Franklin Resources Inc San Mateo, CA1.3MShares$442,7310.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.26MShares$427,2790.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.19MShares$403,3930.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA732KShares$249,0160.33% of portfolio
-
Black Rock Inc. New York, NY573KShares$194,9260.0% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $9.73M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...